Amneal Pharmaceuticals Inc AMRX

US Pharmaceuticals

$18.32 ▼ -0.97% ($-0.18)

Open $18.17

Prev Close $18.50

Day Range $17.92 – $18.43

52W Range $7.67 – $19.26

Market Cap $5.85B

P/E (TTM) 47.91

Beta 1.26

EPS (TTM) $0.37

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2009-11-18
Shares Out.	319,330,000
Website	amneal.com/ ↗
Phone	19089473120
Employees	8,500
Revenue	$722.5M
Gross Profit	$320.1M
Net Income	$78.0M
Free Cash Flow	$241.7M
Total Assets	$3.54B
Total Liabilities	$3.50B
Equity	-$46.0M

About Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Amneal Pharmaceuticals Inc is a publicly traded company under the ticker symbol AMRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.